Dr. Krishnansu Tewari, MD
Claim this profileUC Irvine Health/Chao Family Comprehensive Cancer Center
Affiliated Hospitals
UCI Health - Chao Family Comprehensive Cancer Center
UC Irvine Health/Chao Family Comprehensive Cancer Center
Clinical Trials Krishnansu Tewari, MD is currently running
Olvi-Vec + Chemotherapy
for Ovarian Cancer
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting
2 awards
Phase 3
7 criteria
ZN-c3
for Uterine Cancer
This is a Phase 2 study to evaluate the clinical activity and safety of ZN-c3 (azenosertib) in adult women with recurrent or persistent uterine serous carcinoma (USC).
Recruiting
1 award
Phase 2
6 criteria
More about Krishnansu Tewari, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Krishnansu Tewari, MD has experience with
- Bevacizumab
- Carboplatin
- Paclitaxel
- Pembrolizumab
- Gemcitabine
- Topotecan
Breakdown of trials Krishnansu Tewari, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Krishnansu Tewari, MD specialize in?
Krishnansu Tewari, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved treating patients, or patients who are undergoing treatment.
Is Krishnansu Tewari, MD currently recruiting for clinical trials?
Yes, Krishnansu Tewari, MD is currently recruiting for 6 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Krishnansu Tewari, MD has studied deeply?
Yes, Krishnansu Tewari, MD has studied treatments such as Bevacizumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Krishnansu Tewari, MD?
Apply for one of the trials that Krishnansu Tewari, MD is conducting.
What is the office address of Krishnansu Tewari, MD?
The office of Krishnansu Tewari, MD is located at: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California 92868 United States. This is the address for their practice at the UC Irvine Health/Chao Family Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.